This study investigates whether an experimental medication is effective in slowing the progression of preclinical Alzheimer’s Disease in individuals with mild symptoms with or without a family history of AD.
Principal Investigator
Arash Salardini
Floyd Jones
210-450-3158
jonesfa@uthscsa.edu
Participants must have a study partner who is willing to provide information about the individual’s daily activities. ???????
Recent history of stroke, seizures, or major psychiatric illness. Inability to complete MRI scans.